Ensign Peak Advisors
HLVX

Ensign Peak Advisors’s HilleVax HLVX Stock Holding History

Ensign Peak Advisors’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-311,784
Closed -$4.51M – 1711
2024
Q2 		$4.51M Buy
311,784
+194,038
+165% +$2.67M 0.01% 652
2024
Q1 		$1.96M Hold
117,746
– – ﹤0.01% 933
2023
Q4 		$1.89M Hold
117,746
– – ﹤0.01% 941
2023
Q3 		$1.58M Hold
117,746
– – ﹤0.01% 918
2023
Q2 		$2.02M Hold
117,746
– – ﹤0.01% 873
2023
Q1 		$1.95M Hold
117,746
– – ﹤0.01% 866
2022
Q4 		$1.97M Buy
+117,746
New +$2.13M ﹤0.01% 822

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ensign Peak Advisors's HLVX Position: Q3 2024 in Review

Ensign Peak Advisors sold out of HilleVax (HLVX) in Q3 2024, closing a stake of 311,784 shares — an estimated $4.51M sold.

Ensign Peak Advisors first reported a position in HLVX in Q4 2022 and held it in 7 quarters. The position peaked at $4.51M in Q2 2024. 79 funds tracked by Wall St. Rank hold HLVX as of Q3 2024.

  • Ensign Peak Advisors reported no remaining HilleVax position as of Q3 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 311,784 HilleVax shares in Q3 2024, an estimated $4.51M.
  • Ensign Peak Advisors first reported a position in HilleVax in Q4 2022 and held it in 7 quarters.
  • Ensign Peak Advisors's HilleVax position peaked at $4.51M in Q2 2024.
  • 79 funds tracked by Wall St. Rank held HilleVax as of Q3 2024.

Based on Ensign Peak Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.